← back to search

Matthew Moll

Harvard University · US
Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Genetic Associations and Epidemiology, and Asthma and respiratory diseases.
h-index
27
citations
3,128
works
187
NIH funding
primary concept
Medicine
email

Recent publications

A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease
JAMA 2025cited by 18position: middledoi
Polygenic Risk Score Added to Conventional Case Finding to Identify Undiagnosed Chronic Obstructive Pulmonary Disease
JAMA 2025cited by 17position: lastdoi
Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study
Journal of the American Heart Association 2024cited by 19position: middledoi
Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis–Associated Interstitial Lung Disease Subtypes
Arthritis Care & Research 2024cited by 16position: middledoi
Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine 2024cited by 14position: middledoi
Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies
EBioMedicine 2024cited by 3position: firstdoi
Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk
Nature Genetics 2023cited by 178position: middledoi
A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities
American Journal of Respiratory and Critical Care Medicine 2023cited by 59position: firstdoi
Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing
Nature Genetics 2023cited by 55position: middledoi
Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease
Respiratory Medicine 2023cited by 15position: middledoi
A polygenic risk score and age of diagnosis of COPD
European Respiratory Journal 2022cited by 29position: lastdoi
Polygenic transcriptome risk scores for COPD and lung function improve cross-ethnic portability of prediction in the NHLBI TOPMed program
The American Journal of Human Genetics 2022cited by 24position: middledoi
A robust and adaptive framework for interaction testing in quantitative traits between multiple genetic loci and exposure variables
PLoS Genetics 2022cited by 4position: middledoi
Association of clonal hematopoiesis with chronic obstructive pulmonary disease
Blood 2021cited by 227position: middledoi
Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function
CHEST Journal 2021cited by 48position: middledoi
Associations of Monocyte Count and Other Immune Cell Types with Interstitial Lung Abnormalities
American Journal of Respiratory and Critical Care Medicine 2021cited by 31position: middledoi
A systematic analysis of protein-altering exonic variants in chronic obstructive pulmonary disease
American Journal of Physiology-Lung Cellular and Molecular Physiology 2021cited by 28position: firstdoi
Machine Learning and Prediction of All-Cause Mortality in COPD
CHEST Journal 2020cited by 126position: firstdoi
Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts
The Lancet Respiratory Medicine 2020cited by 124position: firstdoi
COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation 2019cited by 180position: middledoi
Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene
European Respiratory Journal 2019cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brian D. Hobbs · Brigham and Women's Hospital7 papers (2019–2025)Michael H. Cho · Harvard University7 papers (2019–2024)Edwin K. Silverman · Harvard University5 papers (2019–2024)Jingzhou Zhang · Boston University3 papers (2022–2025)Hanfei Xu · Boston University3 papers (2022–2025)Elizabeth A. Regan · University of Alabama at Birmingham3 papers (2019–2024)Dandi Qiao · John Muir Medical Center3 papers (2020–2022)Josée Dupuis · Boston University3 papers (2022–2025)George O'connor · Boston University3 papers (2022–2025)J. Michael Wells · University of Alabama at Birmingham2 papers (2019–2020)Raúl San Jośe Estépar · University of Alabama at Birmingham2 papers (2019–2020)Bartolomé R. Celli · Harvard University2 papers (2020–2024)Gary M. Hunninghake · National Heart Lung and Blood Institute2 papers (2020–2021)David C. LaFon · University of Alabama at Birmingham2 papers (2019–2020)MeiLan K. Han · Seoul National University Hospital2 papers (2019–2020)James D. Crapo · National Jewish Health2 papers (2019–2020)Dawn L. DeMeo · Harvard University2 papers (2022–2022)Barry J. Make · Utrecht University2 papers (2019–2020)George R. Washko · Harvard University2 papers (2019–2020)Pierre‐Antoine Juge · Université Claude Bernard Lyon 11 papers (2024–2024)